Your browser doesn't support javascript.
loading
Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma.
Nie, Jing; Wang, Chunmeng; Liu, Yang; Yang, Qingming; Mei, Qian; Dong, Liang; Li, Xiang; Liu, Jiejie; Ku, Wenjing; Zhang, Yan; Chen, Meixia; An, Xiaojing; Shi, Lu; Brock, Malcolm V; Bai, Jie; Han, Weidong.
Afiliação
  • Nie J; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Wang C; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Liu Y; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Yang Q; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Mei Q; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Dong L; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Li X; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Liu J; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Ku W; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Zhang Y; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Chen M; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • An X; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Shi L; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Brock MV; 2 John Hopkins University, Baltimore, MD.
  • Bai J; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Han W; 1 Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
J Clin Oncol ; 37(17): 1479-1489, 2019 06 10.
Article em En | MEDLINE | ID: mdl-31039052
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article